EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 27.08
-0.33 (-1.19%)
Jan 22, 2026, 1:53 PM GMT
EKF Diagnostics Holdings Revenue
EKF Diagnostics Holdings had revenue of 25.24M GBP in the half year ending June 30, 2025, a decrease of -6.08%. This brings the company's revenue in the last twelve months to 50.22M, down -1.43% year-over-year. In the year 2024, EKF Diagnostics Holdings had annual revenue of 50.19M, down -4.59%.
Revenue (ttm)
50.22M
Revenue Growth
-1.43%
P/S Ratio
2.36
Revenue / Employee
169.09K
Employees
297
Market Cap
118.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 50.19M | -2.42M | -4.59% |
| Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
| Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
| Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
| Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Animalcare Group | 81.07M |
| Animalcare Group | 81.07M |
| Diaceutics | 34.40M |
| Shield Therapeutics | 30.29M |
EKF Diagnostics Holdings News
- 4 months ago - EKF Diagnostics Holdings plc (EKDHF) Q2 2025 Earnings Call Transcript - Seeking Alpha